163 related articles for article (PubMed ID: 31634495)
1. Virtual screening identified compounds that bind to cyclin dependent kinase 2 and prevent herpes simplex virus type 1 replication and reactivation in neurons.
Viegas DJ; Edwards TG; Bloom DC; Abreu PA
Antiviral Res; 2019 Dec; 172():104621. PubMed ID: 31634495
[TBL] [Abstract][Full Text] [Related]
2. A new promising candidate to overcome drug resistant herpes simplex virus infections.
Zinser E; Krawczyk A; Mühl-Zürbes P; Aufderhorst U; Draßner C; Stich L; Zaja M; Strobl S; Steinkasserer A; Heilingloh CS
Antiviral Res; 2018 Jan; 149():202-210. PubMed ID: 29155164
[TBL] [Abstract][Full Text] [Related]
3. Beta interferon plus gamma interferon efficiently reduces acyclovir-resistant herpes simplex virus infection in mice in a T-cell-independent manner.
Huang WY; Su YH; Yao HW; Ling P; Tung YY; Chen SH; Wang X; Chen SH
J Gen Virol; 2010 Mar; 91(Pt 3):591-8. PubMed ID: 19906941
[TBL] [Abstract][Full Text] [Related]
4. The effect of gramicidin, a topical contraceptive and antimicrobial agent with anti-HIV activity, against herpes simplex viruses type 1 and 2 in vitro.
Bourinbaiar AS; Coleman CF
Arch Virol; 1997; 142(11):2225-35. PubMed ID: 9672588
[TBL] [Abstract][Full Text] [Related]
5. Synthetic α-Hydroxytropolones Inhibit Replication of Wild-Type and Acyclovir-Resistant Herpes Simplex Viruses.
Ireland PJ; Tavis JE; D'Erasmo MP; Hirsch DR; Murelli RP; Cadiz MM; Patel BS; Gupta AK; Edwards TC; Korom M; Moran EA; Morrison LA
Antimicrob Agents Chemother; 2016 Apr; 60(4):2140-9. PubMed ID: 26787704
[TBL] [Abstract][Full Text] [Related]
6. Effect of metal complexes of acyclovir and its acetylated derivative on Herpes simplex virus 1 and Herpes simplex virus 2 replication.
Varadinova T; Vilhelmova N; Badenas F; Terrón A; Fiol J; Garcia-Raso A; Genova P
Acta Virol; 2005; 49(4):251-60. PubMed ID: 16402682
[TBL] [Abstract][Full Text] [Related]
7. Antiviral activity of PHA767491 against human herpes simplex virus in vitro and in vivo.
Hou J; Zhang Z; Huang Q; Yan J; Zhang X; Yu X; Tan G; Zheng C; Xu F; He S
BMC Infect Dis; 2017 Mar; 17(1):217. PubMed ID: 28320320
[TBL] [Abstract][Full Text] [Related]
8. Cucumis melo pectin as potential candidate to control herpes simplex virus infection.
Agostinho KF; Rechenchoski DZ; Faccin-Galhardi LC; de Sousa ALN; Cunha AP; Ricardo NMPS; Linhares REC; Nozawa C
FEMS Microbiol Lett; 2021 Mar; 368(4):. PubMed ID: 33565598
[TBL] [Abstract][Full Text] [Related]
9. Lupeol impairs herpes simplex virus type 1 replication by inhibiting the promoter activity of the viral immediate early gene α0.
Ye J; Wang Z; Jia J; Li F; Wang Y; Jiang Y; Wang Y; Ren Z; Pu H
Acta Virol; 2021; 65(3):254-263. PubMed ID: 34565153
[TBL] [Abstract][Full Text] [Related]
10. Comparison of three cell-based drug screening platforms for HSV-1 infection.
D'Aiuto L; Williamson K; Dimitrion P; McNulty J; Brown CE; Dokuburra CB; Nielsen AJ; Lin WJ; Piazza P; Schurdak ME; Wood J; Yolken RH; Kinchington PR; Bloom DC; Nimgaonkar VL
Antiviral Res; 2017 Jun; 142():136-140. PubMed ID: 28342892
[TBL] [Abstract][Full Text] [Related]
11. Discovery of Small-Molecule Inhibitors Targeting the E3 Ubiquitin Ligase Activity of the Herpes Simplex Virus 1 ICP0 Protein Using an
Deschamps T; Waisner H; Dogrammatzis C; Roy A; Chacko S; Perera C; Prisinzano TE; Kalamvoki M
J Virol; 2019 Jul; 93(13):. PubMed ID: 30996104
[TBL] [Abstract][Full Text] [Related]
12. Antiviral activity of 1,4-disubstituted-1,2,3-triazoles against HSV-1 in vitro.
Viegas DJ; da Silva VD; Buarque CD; Bloom DC; Abreu PA
Antivir Ther; 2020; 25(8):399-410. PubMed ID: 33705354
[TBL] [Abstract][Full Text] [Related]
13. Profile of anti-herpetic action of ASP2151 (amenamevir) as a helicase-primase inhibitor.
Yajima M; Yamada H; Takemoto M; Daikoku T; Yoshida Y; Long T; Okuda T; Shiraki K
Antiviral Res; 2017 Mar; 139():95-101. PubMed ID: 28027917
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and Biological Evaluation of Amidinourea Derivatives against Herpes Simplex Viruses.
Toscani A; Denaro R; Pacheco SFC; Biolatti M; Anselmi S; Dell'Oste V; Castagnolo D
Molecules; 2021 Aug; 26(16):. PubMed ID: 34443515
[TBL] [Abstract][Full Text] [Related]
15. Preparation of a monoPEGylated derivative of cyanovirin-N and its virucidal effect on acyclovir-resistant strains of herpes simplex virus type 1.
Lei Y; Chen W; Liang H; Wang Z; Chen J; Hong H; Xie L; Nie H; Xiong S
Arch Virol; 2019 May; 164(5):1259-1269. PubMed ID: 30903291
[TBL] [Abstract][Full Text] [Related]
16. Synergistic effects of acyclovir and 3, 19-isopropylideneandrographolide on herpes simplex virus wild types and drug-resistant strains.
Priengprom T; Ekalaksananan T; Kongyingyoes B; Suebsasana S; Aromdee C; Pientong C
BMC Complement Altern Med; 2015 Mar; 15():56. PubMed ID: 25879785
[TBL] [Abstract][Full Text] [Related]
17. Novel targets for the development of anti-herpes compounds.
Greco A; Diaz JJ; Thouvenot D; Morfin F
Infect Disord Drug Targets; 2007 Mar; 7(1):11-8. PubMed ID: 17346207
[TBL] [Abstract][Full Text] [Related]
18. Frequency of acyclovir-resistant herpes simplex viruses isolated from the general immunocompetent population and patients with acquired immunodeficiency syndrome.
Ziyaeyan M; Alborzi A; Japoni A; Kadivar M; Davarpanah MA; Pourabbas B; Abassian A
Int J Dermatol; 2007 Dec; 46(12):1263-6. PubMed ID: 18173520
[TBL] [Abstract][Full Text] [Related]
19. CDK9 inhibitor FIT-039 prevents replication of multiple DNA viruses.
Yamamoto M; Onogi H; Kii I; Yoshida S; Iida K; Sakai H; Abe M; Tsubota T; Ito N; Hosoya T; Hagiwara M
J Clin Invest; 2014 Aug; 124(8):3479-88. PubMed ID: 25003190
[TBL] [Abstract][Full Text] [Related]
20. Antiviral activity of Viracea against acyclovir susceptible and acyclovir resistant strains of herpes simplex virus.
Thompson KD
Antiviral Res; 1998 Jul; 39(1):55-61. PubMed ID: 9754950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
